NO974846L - Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid - Google Patents

Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid

Info

Publication number
NO974846L
NO974846L NO974846A NO974846A NO974846L NO 974846 L NO974846 L NO 974846L NO 974846 A NO974846 A NO 974846A NO 974846 A NO974846 A NO 974846A NO 974846 L NO974846 L NO 974846L
Authority
NO
Norway
Prior art keywords
ranitidine hydrochloride
preparation
ranitidine
hydrochloride
methyl
Prior art date
Application number
NO974846A
Other languages
English (en)
Norwegian (no)
Other versions
NO974846D0 (no
Inventor
Helmut Schickaneder
Aggelos Nikolopoulos
Original Assignee
Hexal Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Pharmaceuticals Inc filed Critical Hexal Pharmaceuticals Inc
Publication of NO974846D0 publication Critical patent/NO974846D0/no
Publication of NO974846L publication Critical patent/NO974846L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO974846A 1995-04-21 1997-10-20 Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid NO974846L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/426,930 US5663381A (en) 1995-04-21 1995-04-21 Process for preparing form 1 ranitidine hydrochloride
PCT/US1996/000992 WO1996033185A1 (en) 1995-04-21 1996-01-26 A process for preparing form 1 ranitidine hydrochloride

Publications (2)

Publication Number Publication Date
NO974846D0 NO974846D0 (no) 1997-10-20
NO974846L true NO974846L (no) 1997-12-19

Family

ID=23692783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974846A NO974846L (no) 1995-04-21 1997-10-20 Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid

Country Status (17)

Country Link
US (1) US5663381A (cs)
JP (1) JPH11503755A (cs)
KR (1) KR19990007912A (cs)
AU (1) AU691736B2 (cs)
BG (1) BG101982A (cs)
BR (1) BR9608177A (cs)
CA (1) CA2218562A1 (cs)
CZ (1) CZ332097A3 (cs)
EE (1) EE9700291A (cs)
FI (1) FI974002A7 (cs)
HU (1) HUP9801658A2 (cs)
NO (1) NO974846L (cs)
NZ (1) NZ302872A (cs)
PL (1) PL322979A1 (cs)
SI (1) SI9620056A (cs)
SK (1) SK143697A3 (cs)
WO (1) WO1996033185A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004985A (en) * 1996-10-09 1999-12-21 Berlex Laboratories, Inc. Thio acid derived monocylic N-heterocyclics as anticoagulants
US6140351A (en) * 1997-12-19 2000-10-31 Berlex Laboratories, Inc. Ortho-anthranilamide derivatives as anti-coagulants
IT1317858B1 (it) * 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
JP4610485B2 (ja) * 2003-07-29 2011-01-12 大日本住友製薬株式会社 イミド化合物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride

Also Published As

Publication number Publication date
BR9608177A (pt) 2000-10-31
US5663381A (en) 1997-09-02
NZ302872A (en) 1998-04-27
FI974002L (fi) 1997-12-03
KR19990007912A (ko) 1999-01-25
NO974846D0 (no) 1997-10-20
AU691736B2 (en) 1998-05-21
CZ332097A3 (cs) 1998-03-18
PL322979A1 (en) 1998-03-02
FI974002A7 (fi) 1997-12-03
FI974002A0 (fi) 1997-10-20
BG101982A (bg) 1998-04-30
SK143697A3 (en) 1998-05-06
SI9620056A (sl) 1998-04-30
WO1996033185A1 (en) 1996-10-24
HUP9801658A2 (hu) 1999-09-28
EE9700291A (et) 1998-06-15
JPH11503755A (ja) 1999-03-30
CA2218562A1 (en) 1996-10-24
MX9708122A (es) 1998-06-28
AU4903296A (en) 1996-11-07

Similar Documents

Publication Publication Date Title
FI964682A0 (fi) Glukagonia sisältävä farmaseuttinen valmiste
NO965298D0 (no) Ny krystallmodifikasjon av CDCH, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende denne
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
PL293795A1 (en) Method of obtaining cyclic urea derivatives
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
PT94504A (pt) Processo para a preparacao de composicoes farmaceuticas aquosas em suspensao para ingredientes activos substancialmente insoluveis em agua
MX9801716A (es) Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
PL313070A1 (en) Derivatives of n-(3-benzofuranyl)-urea, method of obtaining them and pharmaceutical compositions containing such derivatives
HUP9603237A2 (hu) (R)-(-)-2-{N-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzizotiazol-2-il)-butil]-amino-metil}-kromán kristályos hidrokloridja, eljárás előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
IL99628A0 (en) Backbone cyclic peptides,processes for their preparation and pharmaceutical compositions containing them
HUT52040A (en) Process for producing diaryl-derivatives and pharmaceutical compositions containing them
DE59601683D1 (de) Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
NO961000L (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
HUP9801977A1 (hu) Új indol- és indazolszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
NO975679D0 (no) Metode for fremstilling av N-monosubstituerte og N,N'-disubstituerte usymmetriske cykliske ureaer
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
HUP0001827A2 (hu) Kolchicin-származékok, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények, és a vegyületek alkalmazása gyógyszerkészítmények előállítására
EE03803B1 (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
HUP0303319A2 (hu) 9-Dezoxo-9-dihidro-9a-aza-9a-homoeritromicin A és 5-O-dezozaminil-9-dezoxo-9-dihidro-9a-aza-9a-homoeritronolid A 9a-N-[N'-(fenil-szulfonil)karbamoil]-származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BG101982A (bg) Метод за изготвяне на форма 1 ренитидин хидрохлорид
HUP0004507A1 (hu) Ketolidok alkalmazása atheroszklerózissal kapcsolatos artériás trombózis- komplikációk megelőzésére alkalmas gyógyszerkészítmény előállítására
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate